12 US research organizations collaborated to produce Utility of [15] Candidate Genes From an Algorithm Designed to Predict Genetic Risk for Opioid Use Disorder. But results suggest that these genetic variants do not meet reasonable standards of efficacy in identifying OUD risk – more clinically useful models are needed.


